Sessions are Mondays from 12:00-1:30pm.

* please note the curriculum topics are subject to change without notice.

Cycle 3 cont:  

Session/Date Topic Presenter(s)
1-Jan-18 No Session
S11 – 8-Jan-18 Best practice in management of Genotype 4-6 Dr. Hemant Shah
S12 – 15-Jan-18 Tools to aid Treatment – HepMD Dr. Jordan Feld
S13 – 22-Jan-18 Getting Hep C Therapy Approved in Ontario – EAP Tips Dr. Hemant Shah
S14 – 29-Jan-18 After Hep C Therapy: Long Term Monitoring Dr. Jordan Feld
S15 – 5-Feb-18 Open Session – Participant Selected Didactic Topic Dr. Hemant Shah

 

Cycle 4: ECHO Liver

Date Didactic Topic Presenter(s)
S1 – 12-Feb-18 Introduction to Liver Disease and ECHO Liver Dr. Jordan Feld
19-Feb-18 No Session  
S2 – 26-Feb-18 Who is at risk?  Natural History, Screening  & Diagnosis Dr. Hemant Shah
S3 – 5-Mar-18 Fibrosis Assessment and Introduction to Cirrhosis Dr. Jordan Feld
12-Mar-18 No session
S4 – 19-Mar-18 Hep C: Treatment Decision Making, Readiness and Principles Dr. Craig Kuhn
S5 – 26-Mar-18 Epidemiology of Hep B & C in Canada Dr. Hemant Shah
2-Apr-18 No Session  
S6 – 9-Apr-18 Cirrhosis: Management of Key Complications Dr. Hemant Shah
16-Apr-18 No Session
S7 – 23-Apr-18 Hep C – Best Practice Management of Genotype 1 Dr. Hemant Shah
S8 – 30-Apr-18 Hep C – Best Practice Management of Genotype 2-6 Dr. Jordan Feld
S9 – 7-May-18 Hep C: After Hep C Therapy – Long Term Monitoring & Follow-up Dr. Jordan Feld
S10 – 14-May-18 Hep B: What do the tests mean & Vaccination Dr. Jordan Feld
21-May-18 No Session  
28-May-18 No Session
S11 -4-Jun-18 Hep B: Treatment Options (acute & chronic) Dr. Jordan Feld
S12 – 11-Jun-18 Alcoholic Liver Disease Dr. Hemant Shah
S13 – 18-Jun-18 Fatty Liver: Diagnosis, Treatment & Management Dr. Jordan Feld
S14 – 25-Jun-18 Symptom Management:  Managing psychosocial health (i.e. sleep, depression,) Richard Yanofsky
 2-Jul-18 No Session  
S15 – 9-Jul-18 Treatment Management: Alcohol and Liver Disease Dr. Jordan Feld
S16 – 16-Jul-18 Open Didactic Session – Participation selected topics Dr. Hemant Shah

 

Cycle 5: ECHO Liver

Date Didactic Topic Presenter(s)
S1 – 23-Jul-18 Introduction to Liver Disease and ECHO Liver Dr. Jordan Feld
S2 – 30-Jul-18 Who is at risk?  Natural History, Screening  & Diagnosis Dr. Hemant Shah
6-Aug-18 No Session
S3 – 13-Aug-18 Initial Assessment, Data Gathering Dr. Jordan Feld
S4 -20-Aug-18 Cirrhosis: Management of Key Complications Part 1 Dr. Jordan Feld
27-Aug-18 No Session (Summer break)
3-Sep-18 No Session (Summer break)
S5 -10-Sep-18 Cirrhosis: Management of Key Complications Part 2 Dr. Hemant Shah
S6 – 17-Sep-18 Epidemiology of Hep B & C &NAFLD in Canada Dr. Hemant Shah
S7 – 24-Sep-18 Hep C: Treatment Decision Making, Readiness and Principles, Ontreatment Monitoring Dr. Jordan Feld
S8 – 1-Oct-18 Hep C: Best Practice Management of Genotype 1 Dr. Hemant Shah
8-Oct-18 No Session
S9 -15-Oct-18 Hep C: – Best Practice Management of Genotype 2-6 Dr. Jordan Feld
S10 – 22-Oct-18 Hep C: After Hep C Therapy – Long Term Monitoring & Follow up Dr. Hemant Shah
S11 – 29-Oct-18 Hep B: What do the tests mean & Vaccination Dr. Hemant Shah
S12 – 5-Nov-18 Hep B: Treatment Options (acute & chronic) Dr. Jordan Feld
12-Nov-18 No Session
S13 – 19-Nov-18 Hep B: Pregnancy, Children & Immune Suppression Dr. Hemant Shah
S14 – 26-Nov-18 Alcoholic liver disease Dr. Jordan Feld
S15 – 3-Dec-18 Fatty Liver: Diagnosis, Treatment & Management Dr. Jordan Feld
S16 – 10-Dec-18 Symptom Management – Side effects of medications and resources needed for successful treatment Ruifen Su & Magdalena Kuczynski
S17 – 17-Dec-18 Treatment Management – Motivational Interviewing: Engaging patients to go on and stay on treatment Richard Yanofsky
24-Dec-18 No Session (Christmas)
31-Dec-18 No Session (Christmas)